Nitazoxanide pharmacokinetics and tolerability in man during 7 days dosing with 0.5 g and 1 g b.i.d

International Journal of Clinical Pharmacology and Therapeutics

Volumn 40, Issue 5, 2002, Pages 221-227

  Stockis, A ^a   De Bruyn, S ^a   Gengler, C ^a   Rosillon, D ^a  

^a UCB PHARMA   (Belgium)

Author keywords

Antiprotozoal; Glucuronide; Nitazoxanide; Pharmacokinetics; Tizoxanide

Indexed keywords

ANTIPARASITIC AGENT; NITAZOXANIDE; PLACEBO; TIZOXANIDE;

ABDOMINAL DISCOMFORT; ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG ACCUMULATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG TOLERABILITY; ELECTROCARDIOGRAPHY; FOOD INTAKE; GASTROINTESTINAL DISEASE; HUMAN; HUMAN EXPERIMENT; LABORATORY TEST; MALE; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; VOLUNTEER;

EID: 0036245589     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP40221     Document Type: Article

References (9)

1. Nitazoxanide: Pharmacokinetics and metabolism in man
2. Categorical data analysis
3. Synthesis and antibacterial activities of tizoxanide, an N-(nitrothiazolyl)salicylamide, and its O-aryl glucuronide
4. Update on the statistical analysis of bioequivalence studies
5. Pharmacokinetics of nitazoxanide after single dose oral administration in 6 healthy volunteers
6. Nitazoxanide pharmacokinetics and tolerability in man after single ascending oral doses